期刊文献+

大肠癌患者K-ras基因突变情况及临床意义 被引量:3

K-ras mutation and its clinical significance in patients with colorectal cancer
原文传递
导出
摘要 目的研究大肠癌患者K-ras基因的突变情况及其与临床病理特征间的关系。方法应用RT-PCR方法检测148例大肠癌患者组织标本K-ras基因第12和13密码子的突变情况,并与其临床病理特征进行对照。结果 148例大肠癌患者K-ras基因突变率为31.8%(47/148)。K-ras基因第12和13密码子突变在不同性别、肿瘤直径、大体形态、肿瘤部位、远处及淋巴结转移方面差异无统计学意义(P>0.05),在不同年龄与不同临床分期上差异有统计学意义(P<0.05)。结论 RT-PCR可准确检测K-ras基因突变情况,K-ras基因突变与患者年龄、肿瘤临床分期关系密切。 Objective To investigate the mutation of K-ras gene in colorectal cancer and its correlation with clinical and pathological features.Methods A total of 148 colorectal cancer tissue samples were detected the mutation of codon 12 and codon 13 in K-ras gene with reverse transcription-PCR assay and compared with their clinicopathological features.Results The mutation rate of K-ras gene in 148 cases of sporadic colorectal cancer was 31.8%(47/148).The mutation of codon 12 and 13 of K-ras gene was not significantly different in gender,age,diameter of tumor,gross morphology,tumor location,distant metastasis or lymph node metastasis(P0.05),but was significantly different in age and clinical stage(P0.05).Conclusion Reverse transcription-PCR can accurately detect K-ras gene mutation,which is closely correlated with patient's age and clinical stage.
出处 《中华实用诊断与治疗杂志》 2011年第9期850-852,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 河南省社会公益项目预研专项课题基金(082103810508)
关键词 大肠癌 K—ras基因 突变 Colorectal cancer K-ras gene mutation
  • 相关文献

参考文献17

二级参考文献151

共引文献95

同被引文献21

  • 1雷文斌,苏振忠,文卫平,柴丽萍,蒋爱云,廖冰.喉癌切缘中eIF4E、p53、ras和c-myc表达与预后的研究[J].中山大学学报(医学科学版),2007,28(5):545-549. 被引量:4
  • 2Kopetz S, Chang GJ, Overman M J, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy [J]. J Clin Oncol, 2009, 27 (22) : 3677-3683.
  • 3Roth AD, Tejpar S, Deloromi M, et 8]. Prognostic role of K-ras and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60- 00 trial [J]. J Clin Oncol, 2010, 28 (3) : 466-474.
  • 4Briese J, Chen S, Ezzal S, et al. Osteopontin (OPN) expression in thyroid carcinoma[J]. Anticancer Res, 2010,30(5): 1681- 1688.
  • 5Rittling S R, Chambers A F. Role of osteopontin in tumor progression[J]. Br J Cancer, 2004,90(10) :1877-1881.
  • 6Wai P Y, Kuo P C. The role of osteopontin in tumor metastasis [J]. SurgRes,2004,121(2):228 -241.
  • 7Sung H J, Cho J Y. Biomarkers for the lung cancer diagnosis and their advances in proteomics[J].JBMB,2008,41(9) :615.
  • 8Denhardt D T, Mistretta D, Chambers A F, ee ag. Transcriptional regulation of osteopontin and the metastatic phenotype. Evidence for a ras activated enhaned in the human apn promter[J]. Clin Exp Metastasis, 2003,20 (1) : 77 84.
  • 9Wu Y, Denhardt D T, Rittling S R. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene[J]. Br J Cancer, 2000,83(2) : 156-163.
  • 10徐德魁,于洪波,郑长青.微卫星不稳定性检测在大肠癌研究中的应用[J].中华实用诊断与治疗杂志,2009,23(6):521-523. 被引量:3

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部